Chronic Sinusitis Associated With Certain Rare Head and Neck Cancers among Elderly, Although AbsoluChronic sinusitis associated with certain rare head and neck cancers among elderly, although absolut
(The JAMA Network Journals) In a study published online by JAMA Otolaryngology-Head& Neck Surgery, Daniel C. Beachler, Ph.D., M.H.S., and Eric A. Engels, M.D., M.P.H., of the National Cancer Institute, Bethesda, Md., evaluated the associations of chronic sinusitis with subsequent head and neck cancer in an elderly population. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 8, 2016 Category: Cancer & Oncology Source Type: news
Dr. Richard Rosenfeld recommends shared decision-making in treating adult sinusitis
(SUNY Downstate Medical Center) In an article in the New England Journal of Medicine, SUNY Downstate Medical Center's Distinguished Professor and Chair of Otolaryngology Richard M. Rosenfeld, M.D., M.P.H., recommends a process of shared decision-making between physicians and patients in the treatment of adult sinusitis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 7, 2016 Category: Infectious Diseases Source Type: news
Intersect ENT claims reimbursement win for Propel drug-eluting sinus implant
Intersect ENT (NSDQ:XENT) said today that it won a positive coverage decision from CareFirst BlueCross BlueShield for its Propel and Propel Mini drug-eluting sinus implants.
The devices are designed to elute the anti-inflammatory steroid mometasone furoate; Menlo Park, Calif.-based Intersect won FDA approval for the original Propel implant in August 2011 and for the Propel Mini the following September. The implants are designed to dissolve into the body over time.
CareFirst BlueCross BlueShield has some 3.2 million lives under coverage in Washington, D.C., Maryland and northern Virginia, including more than 577,000 in...
Source: Mass Device - August 29, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Drug-Device Combinations Ear Nose & Throat (ENT) Intersect ENT Inc. Reimbursement Source Type: news
Well: Living Near a Fracking Site Is Tied to Migraines, Fatigue
Living near a natural gas hydraulic fracturing site is associated with increased rates of sinus problems, migraines and fatigue, according to new research. (Source: NYT Health)
Source: NYT Health - August 25, 2016 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Fatigue Headaches Hydraulic Fracturing Migraine Headaches Sinusitis Featured Live Source Type: news
Intersect ENT files with FDA for drug-delivering sinus implant
Intersect ENT (NSDQ:XENT) said today it submitted a supplemental premarket approval submission to the FDA seeking approval for a new Nova steroid releasing implant for treating patients with chronic sinus disease.
The new Nova device is designed with a lower profile to allow for placement in smaller sinus openings, and will expand the usable patient population for the steroid releasing implants, the Menlo Park, Calif.-based company said.
“This submission is another important milestone in our efforts to address unmet needs for chronic sinusitis patients across the continuum of care. Nova design, which allows for pl...
Source: Mass Device - August 1, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Drug-Device Combinations Food & Drug Administration (FDA) Otolaryngology Ear, Nose & Throat Regulatory/Compliance Intersect ENT Inc. Source Type: news
Fluoroquinolone Label Warning Strengthened by FDA Fluoroquinolone Label Warning Strengthened by FDA
The FDA updated fluoroquinolone labeling to warn against routine use in patients with acute bacterial sinusitis, acute exacerbation of chronic bronchitis, and uncomplicated urinary tract infections. < br / > < i > News Alerts < /i > (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 27, 2016 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news
Acclarent launches Relieva Scout multi-sinus dilator
Johnson & Johnson (NYSE:JNJ) subsidiary Acclarent said Wednesday it is launching the Relieva Scout multi-sinus dilation system in the U.S.
The Relieva Scout is designed to use balloon sinuplasty technology to confirm and dilate sinus openings in individuals with chronic sinusitis through a minimally-invasive procedure.
“I’m always looking for new technologies that enable me to better address the needs of those suffering from chronic sinusitis. The Relieva Scout Multi-Sinus Dilation System brings together the benefits of tactile feedback and greater reach in an easy-to-use, precise device, which helps me sa...
Source: Mass Device - July 22, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Otolaryngology Ear, Nose & Throat Acclarent Inc. Source Type: news
Study: Neti pots really do help chronic sinusitis
Using a neti pot with a salt solution can eliminate some symptoms of chronic sinusitis, new research found. In fact, the study published in the Canadian Medical Association Journal showed patients who used this old-school technique were able to maintain positive results over a six month period. < div class="feedflare" > < a href="http://rss.cnn.com/~ff/rss/cnn_health?a=JPEbwYGm9Yc:TZVOkmmuvB8:yIl2AUoC8zA" > < img src="http://feeds.feedburner.com/~ff/rss/cnn_health?d=yIl2AUoC8zA" border="0" > < /img > < /a > < a href="http://rss.cnn.com/~ff/rss/cnn_health?a=JPEbwYGm9Yc:TZVOkmmuvB8:7Q72WNTAKBA" > < img src="http://feeds.feed...
Source: CNN.com - Health - July 21, 2016 Category: Consumer Health News Source Type: news
Neti Pot Beats Steam for Sinus Congestion Relief
Rinsing nasal passages with saline solution may improve symptoms, study saysSource: HealthDay
Related MedlinePlus Pages: Allergy, Common Cold, Sinusitis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 18, 2016 Category: Consumer Health News Source Type: news
Neti Pot Beats Steam for Sinus Congestion Relief
MONDAY, July 18, 2016 -- Inhaling steam probably won't open your chronically clogged sinuses. But nasal irrigation may bring some relief, a new study finds.
"People with chronic and recurrent sinusitis have poor quality of life, similar to having a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 18, 2016 Category: Journals (General) Source Type: news
Advising Sinusitis Patients to Use Nasal Irrigation May Help Improve Symptoms (FREE)
By Kelly Young
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
Patients with chronic or recurrent sinusitis who were advised to use nasal irrigation had a modest reduction in symptoms, according … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 17, 2016 Category: Primary Care Source Type: news
FDA clears Vent-Os sinus dilation devices from SinuSys
SinuSys said today it won FDA 510(k) clearance for 2 new Vent-Os sinus dilation devices designed for treating sinusitis symptoms.
The Palo Alto, Calif.-based company said it won clearance for 2 new devices which allow dilation of the frontal and sphenoid sinuses.
“The Vent-Os system is easy to deploy and enables physicians to bring the benefits of minimally invasive sinus dilation to their patients in an office procedure that is highly tolerable under topical or local anesthesia. By adding devices for treatment of the frontal and sphenoid sinuses, an expanded group of patients will be able to benefit from this simple...
Source: Mass Device - July 13, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Otolaryngology Ear, Nose & Throat Regulatory/Compliance SinuSys Source Type: news
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
PALO ALTO, Calif.--(Healthcare Sales & Marketing Network)--SinuSys Corporation, an innovative sinus health company, today announced receipt of FDA clearance for a full family of sinus dilation devices, adding two new devices that will expand the companys ... Devices, FDASinuSys, Vent-Os, sinus dilation, sinusitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 13, 2016 Category: Pharmaceuticals Source Type: news
